APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rotavirus Vaccine Market Outlook and Growth Opportunities 2026

Report ID 174033580419 December 2025199 pages

Choose your research edition.

Industry ResearchRotavirus Vaccine Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Rotavirus Vaccine Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rotavirus Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Rotavirus Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rotavirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rotavirus Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rotavirus Vaccine market include GlaxoSmithKline Biologicals, Lanzhou Institute of Biological Products and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rotavirus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rotavirus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rotavirus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rotavirus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Rotavirus Vaccine Segment by Company

GlaxoSmithKline Biologicals

Lanzhou Institute of Biological Products

Merck

Rotavirus Vaccine Segment by Type

RV3

RV5

Rotavirus Vaccine Segment by Application

Government Institution

Private Sector

Other

Rotavirus Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Rotavirus Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rotavirus Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rotavirus Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Rotavirus Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rotavirus Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rotavirus Vaccine industry.

Chapter 3: Detailed analysis of Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rotavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rotavirus Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rotavirus Vaccine Industry Trends Table 2. Rotavirus Vaccine Industry Drivers Table 3. Rotavirus Vaccine Industry Opportunities and Challenges Table 4. Rotavirus Vaccine Industry Restraints Table 5. Global Rotavirus Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rotavirus Vaccine Revenue Share by Company (2021-2026) Table 7. Global Rotavirus Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Rotavirus Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Rotavirus Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Rotavirus Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rotavirus Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Rotavirus Vaccine Company, Product Type & Application Table 13. Global Rotavirus Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of RV3 Table 18. Significant Companies of RV5 Table 19. Global Rotavirus Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Rotavirus Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Rotavirus Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Rotavirus Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Rotavirus Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Rotavirus Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rotavirus Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Rotavirus Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Rotavirus Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Rotavirus Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Government Institution Table 30. Significant Companies of Private Sector Table 31. Significant Companies of Other Table 32. Global Rotavirus Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Rotavirus Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Rotavirus Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Rotavirus Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Rotavirus Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Rotavirus Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Rotavirus Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Rotavirus Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Rotavirus Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Rotavirus Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Rotavirus Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Rotavirus Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Rotavirus Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Rotavirus Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Rotavirus Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Rotavirus Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Rotavirus Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Rotavirus Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Rotavirus Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Global Rotavirus Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Rotavirus Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Rotavirus Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Rotavirus Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Rotavirus Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Rotavirus Vaccine Sales Value Market Share by Country (2027-2032) Table 64. GlaxoSmithKline Biologicals Company Information Table 65. GlaxoSmithKline Biologicals Business Overview Table 66. GlaxoSmithKline Biologicals Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolio Table 68. GlaxoSmithKline Biologicals Recent Development Table 69. Lanzhou Institute of Biological Products Company Information Table 70. Lanzhou Institute of Biological Products Business Overview Table 71. Lanzhou Institute of Biological Products Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolio Table 73. Lanzhou Institute of Biological Products Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Rotavirus Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merck Rotavirus Vaccine Product Portfolio Table 78. Merck Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Rotavirus Vaccine Distributors List Table 82. Rotavirus Vaccine Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Rotavirus Vaccine Product Image Figure 2. Global Rotavirus Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Rotavirus Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Rotavirus Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. RV3 Image Figure 10. RV5 Image Figure 11. Global Rotavirus Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Rotavirus Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Rotavirus Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Rotavirus Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Rotavirus Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Rotavirus Vaccine Sales Value Share by Type (2021-2032) Figure 17. Government Institution Image Figure 18. Private Sector Image Figure 19. Other Image Figure 20. Global Rotavirus Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Rotavirus Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Rotavirus Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Rotavirus Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Rotavirus Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Rotavirus Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Rotavirus Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Rotavirus Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Rotavirus Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Rotavirus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Rotavirus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Rotavirus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Rotavirus Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Rotavirus Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • RV3
  • RV5
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GlaxoSmithKline Biologicals
  • Lanzhou Institute of Biological Products
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rotavirus Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Rotavirus Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Rotavirus Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rotavirus Vaccine Market Dynamics
  1. 2.1 Rotavirus Vaccine Industry Trends
  2. 2.2 Rotavirus Vaccine Industry Drivers
  3. 2.3 Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Rotavirus Vaccine Industry Restraints
3 Rotavirus Vaccine Market by Company
  1. 3.1 Global Rotavirus Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Rotavirus Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Rotavirus Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Rotavirus Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Rotavirus Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Rotavirus Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Rotavirus Vaccine Company Product Type and Application
  8. 3.8 Global Rotavirus Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rotavirus Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rotavirus Vaccine Market by Type
  1. 4.1 Rotavirus Vaccine Type Introduction
  2. 4.1.1 RV3
  3. 4.1.2 RV5
  4. 4.2 Global Rotavirus Vaccine Sales Volume by Type
  5. 4.2.1 Global Rotavirus Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rotavirus Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Rotavirus Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Rotavirus Vaccine Sales Value by Type
  9. 4.3.1 Global Rotavirus Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rotavirus Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Rotavirus Vaccine Sales Value Share by Type (2021-2032)
5 Rotavirus Vaccine Market by Application
  1. 5.1 Rotavirus Vaccine Application Introduction
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Rotavirus Vaccine Sales Volume by Application
  6. 5.2.1 Global Rotavirus Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rotavirus Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rotavirus Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rotavirus Vaccine Sales Value by Application
  10. 5.3.1 Global Rotavirus Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rotavirus Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rotavirus Vaccine Sales Value Share by Application (2021-2032)
6 Rotavirus Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rotavirus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Rotavirus Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Rotavirus Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Rotavirus Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rotavirus Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rotavirus Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rotavirus Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Rotavirus Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rotavirus Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rotavirus Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rotavirus Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rotavirus Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rotavirus Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rotavirus Vaccine Sales Value Share by Country, 2025 VS 2032
7 Rotavirus Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Rotavirus Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rotavirus Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rotavirus Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Rotavirus Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Rotavirus Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Rotavirus Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rotavirus Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rotavirus Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rotavirus Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rotavirus Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rotavirus Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline Biologicals
  2. 8.1.1 GlaxoSmithKline Biologicals Company Information
  3. 8.1.2 GlaxoSmithKline Biologicals Business Overview
  4. 8.1.3 GlaxoSmithKline Biologicals Rotavirus Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Biologicals Rotavirus Vaccine Product Portfolio
  6. 8.1.5 GlaxoSmithKline Biologicals Recent Developments
  7. 8.2 Lanzhou Institute of Biological Products
  8. 8.2.1 Lanzhou Institute of Biological Products Company Information
  9. 8.2.2 Lanzhou Institute of Biological Products Business Overview
  10. 8.2.3 Lanzhou Institute of Biological Products Rotavirus Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lanzhou Institute of Biological Products Rotavirus Vaccine Product Portfolio
  12. 8.2.5 Lanzhou Institute of Biological Products Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Rotavirus Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Rotavirus Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rotavirus Vaccine Value Chain Analysis
  2. 9.1.1 Rotavirus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rotavirus Vaccine Sales Mode & Process
  6. 9.2 Rotavirus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rotavirus Vaccine Distributors
  9. 9.2.3 Rotavirus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst